The agency highlighted small sample sizes, inconsistent baseline characteristics, varying regimens, inadequate controls and uncertain clinical relevance
Pebble Plaza Store Browsing different sections was enjoyable, images are sharp and informative
Multiple studies have indicated that GLP-1s may improve a wide range of mental health outcomes, such as depressive symptoms and alcohol and substance use disorders
Recent pharmacovigilance research has identified elevated reporting odds ratios for hair loss with semaglutide (2.46) and tirzepatide (1.73), suggesting a real association between these medications and increased shedding
The molecular structure of semaglutide is slightly modified from that of endogenous GLP-1 to increase its stability and half-life, enhancing its therapeutic outcomes as a weight loss agent and beyond [3, 4, 5]
While more research is needed, this case report suggests that Glutathione may help reduce symptoms, improving the quality of life in people with this disease